top of page


Head & Shoulders Sells Skincare Claims on a 1.8% Drug
The Scalp Care Collection runs on 1.8 percent salicylic acid or 1 percent zinc pyrithione. In the US both are drug actives. In the EU one is banned.
24 minutes ago


Douglas Changes CEO at 3.1x Leverage. The Fix Is Margin, Not Growth.
Douglas named Jean-Marc Bellaiche CEO on October 14, 2026, with like-for-like sales down 4.5% and net leverage at 3.1 times. K-beauty is not in the release.
1 day ago


Kolmar Can See the Fakes. It Can't Sue a Single One.
Kolmar Korea named overseas counterfeits as K-beauty's biggest problem. The manufacturer holds no trademark, and a US sunscreen is a drug, not a cosmetic.
2 days ago


K-Patch Isn't a New Category. It's a Gap on Ulta's Shelf, in Just 504 Stores
MARSHIQUE enters 504 of Ulta's 1,534 US stores on November 1. Ulta's K-Beauty filter already returns 65 patch products, almost none for wrinkles.
3 days ago


Galderma's $1.5bn ZO Deal Buys 16,500 Doctors, Not a Formula
Galderma signed a US$1.5bn all-cash deal for ZO Skin Health on October 14, 2026. The asset is 16,500 physician accounts, not a patent.
4 days ago
Latest Analysis
bottom of page







